PROCEPT BioRobotics Corporation (NasdaqGM: PRCT)
Health Care · Health Care Equipment & Supplies · US
$19.34
+5.11% today · -47.2% 1Y
PROCEPT BioRobotics Corporation (NasdaqGM: PRCT) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $1.05B and employs 888 people.
Over the last twelve months the share price has lost 47.2%, trading between 16.67 and 38.11.
Tweenvest scores PROCEPT BioRobotics Corporation across four factors: quality 49/100, value 53/100, growth 100/100. Its strongest factor is growth.
PRCT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.05B
- Revenue (TTM)
- $337.34M
- P/E
- —
- EPS
- -1.95
- Dividend yield
- —
- Beta (5Y)
- 0.92
- 52-week high
- $38.11
- 52-week low
- $16.67
- Avg volume (3M)
- —
- Shares outstanding
- 57.27M
- Employees
- 888
- Next earnings
- —
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System, a sophisticated, image-guided surgical robot designed for minimally invasive urological procedures. This system primarily facilitates Aquablation therapy, which the company also devised, to alleviate lower urinary tract symptoms in male patients diagnosed with benign prostatic hyperplasia (BPH). As of year-end 2021, PROCEPT BioRobotics had successfully deployed 130 AquaBeam Robotic Systems across the globe, with a significant majority—78 units—located in the United States. Founded in 2007, the corporation maintains its headquarters in Redwood City, California.
- ISIN
- US74276L1052
- Founded
- 2007
- Listed since
- Sep 15, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Beijing Wandong Medical Technology Co.,Ltd.SHSE: 600055 | $1.09B | CN¥10.48 | -1.13% |
| STAAR Surgical CompanyNasdaqGM: STAA | $1.09B | $21.56 | -0.51% |
| Innovita Biological Technology Co., Ltd.SHSE: 688253 | $1.08B | CN¥53.80 | -0.96% |
| GVS S.p.A.BIT: GVS | $1.07B | €5.30 | +3.72% |
| Integra LifeSciences Holdings CorporationNasdaqGS: IART | $1.05B | $13.88 | +3.27% |
| Artivion, Inc.NYSE: AORT | $1.04B | $21.40 | +0.66% |
| Aidite (Qinhuangdao) Technology Co., Ltd.SZSE: 301580 | $1.04B | CN¥46.50 | -7.20% |
| Tinavi Medical Technologies Co., Ltd.SHSE: 688277 | $1.03B | CN¥14.85 | -5.05% |
Figures last refreshed Oct 11, 2026.